Discovery Alaska Ltd (ASX: DAF) director Jerko Zuvela joins Jonathan Jackson in the Proactive Australia studio to discuss a “transformational” agreement to conduct mineral exploration, mineral development and production activities at the Vinasale Gold Project in Alaska. The binding agreement with Doyon Ltd, an Alaska Native Regional Corporation, is expected to significantly advance Discovery Alaska’s growth strategy. The project has been inactive for 10 years, when the gold price was just US$2000 per ounce. The project also hosts a reported historical NI 43-101 inferred resource of 22 million tonnes averaging 1.53 g/t gold for 1.08 million ounces of gold and indicated resources of 2.29 million tonnes at 1.84 g/t for 135,000 ounces (using a 1g/t cut-off grade) at the Central Zone prospect. Jerko discusses the resource and the period of growth he believes the company is set to go through as work begins at Vinasale and it becomes the company’s primary asset.

#ProactiveInvestors #DiscoveryAlaska #ASX #gold #AlaskanGold #PreciousMetals #GoldPrice

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company announced a $240 million fundraise.

Dr Vitt gives an overview of the fundraise, explaining that it endows Immunic with the necessary resources to advance its work with Vidofludimus Calcium for the treatment of Multiple Sclerosis (MS). The fundraise has drawn in both new and existing investors.

The company plans to use these funds primarily to complete their Phase 2 clinical study in progressive MS, with data expected by April 2025. This study is seen as a major catalyst in Immunic's journey, given the high unmet medical needs in progressive MS and the demand for safer molecules in relapsing MS.

Dr Vitt also highlightsvthe company's progress in 2023, including positive results from a Phase 2 trial in ulcerative colitis and the discovery of a new mode of action for Vidofludimus Calcium in MS. Furthermore, their second molecule, IMU-856, showed positive results in treating celiac disease.

Looking ahead, he says Immunic expects to pass several other important milestones during 2024.

#ImmunicInc #DanielVitt #HealthcareInnovation #MultipleSclerosis #MSResearch #ClinicalTrials #BiotechIndustry #FundraisingNews #PharmaceuticalAdvances #ProgressiveMS #RelapsingMS #VidofludimusCalcium #MedicalBreakthroughs #CEOInterview #BiotechFinancing #HealthSector #UlcerativeColitis #CeliacDisease #HealthcareTechnology #MedicalResearch #PharmaNews #NASDAQ #HealthcareFunding #BiopharmaDevelopments #InnovativeMedicine #MedicalScience #HealthInvestment #BiotechTrends #2024Healthcare

#ProactiveInvestors #funding #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

OptionsDesk broker Richard Perry rounds out the first week of 2024 by speaking to Thomas Warner from Proactive about US inflation trends, interest rates and the impact of recent events on trade and markets.

Perry focuses on the Federal Reserve's stance on interest rates, indicating a "higher for longer" approach despite earlier expectations of rate cuts. This view aligns with recent non-farm payroll data showing robust job growth and stagnant wage growth, suggesting sustained consumer price elevation and a potential delay in interest rate reductions.

Perry also highlights the escalating situation in the Red Sea, where rebel attacks on shipping are affecting trade. Regarding market reactions, Perry observed an uptick in traders buying put options for downside protection, especially as equities fall following recent economic figures. This trend reflects investors' caution amidst uncertain market conditions.

Overall, Perry's emphasises the resilience of the labour market, the persistent challenge of inflation, and the cautious approach of market participants in response to global uncertainties.

#RichardPerry #Optionsdesk #EconomicAnalysis #USInflation #FederalReserve #InterestRates #NonFarmPayroll #WageGrowth #ConsumerPrices #GlobalTrade #RedSeaConflict #ShippingCosts #InflationImpact #MarketTrends #TradingOptions #PutOptions #FinancialMarkets #EconomicTrends2024 #ProactivInterview #FinancialInsights #BrokersPerspective #EconomicOutlook #MonetaryPolicy #LaborMarket #GlobalEconomicImpact #InvestmentStrategies #FinancialPlanning #EconomicNews #FinancialExpert #MarketAnalysis #GlobalEconomics

#ProactiveInvestors #optionstrading #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Proactive Investors' Crypto expert William Farrington speaks to Thomas Warner about the latest developments in cryptocurrency, particularly focusing on Bitcoin's performance and ETF applications.

The interview highlights a midweek dip in Bitcoin's value, primarily attributed to a research piece from Matrixport that contradicted market expectations regarding Bitcoin ETF approvals. This led to a 4-5% decrease in bitcoin's price, underscoring the market's sensitivity and relative immaturity.

Farrington notes bitcoin's swift recovery, climbing back above $44,000 but remaining below the $45,000 mark. He emphasises the impact of US macroeconomic news, particularly labor figures and persistent high interest rates, on Bitcoin's value. These factors introduce downward pressure on Bitcoin and risk-on equities, as the market anticipated a decrease in interest rates.

The discussion also covers Grayscale's position at the forefront of spot bitcoin ETF applications. Farrington's interaction with Grayscale's chief legal officer revealed a surprisingly positive relationship with regulators, countering the common narrative of hostility between the crypto community and the SEC. Despite challenges, including selling pressure on the Grayscale Bitcoin Trust, the fund remains robust, with a discount of under 10%.

Additionally, the interview touched on the legal proceedings involving FTX's founder, emphasising the decision to focus on his initial guilty verdict for market manipulation and fraud, rather than extending the trial with political donation allegations.

#Cryptocurrency #Bitcoin #CryptoNews #ETF #BitcoinMarket #CryptoMarket #DigitalCurrency #Blockchain #CryptoInvesting #BitcoinETF #CryptoAnalysis #MarketTrends #BitcoinPrice #CryptoRegulation #SEC #Grayscale #CryptoCommunity #BitcoinUpdate #FinancialNews #ProactivInterview #ProactiveInvestors #crypto #bitcoin #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Arrow Exploration Corp CEO Marshall Abbott discusses the company's strong position for 2024 in an interview with Proactive's Stephen Gunnion.

With a $45 million capital expenditure budget, self-funded by cash and cash flow, Arrow plans to drill 15 wells, focusing on infill and development.

The company's production run-rate exceeded 3,200 barrels of oil equivalent in 2023. With a potential 40 million barrels in place and a doubled reserve value, Arrow aims to double production in 2024.

The focus is on the Tapir block and Carrizales Norte (CN) field development. Three horizontal wells and seven vertical wells at CN aim to ramp up production capability, whilst additional ‘low risk’ exploration wells are also planned.

At the Oso Pardo field, the company is planning to conduct reservoir stimulations of the Oso Pardo-3 and Oso Pardo-4 wells – which during testing were deemed to have reservoir damage (due to high mud weight used in drilling). This work is slated to take place in the first quarter prior to those wells coming online for production.

#ArrowExploration #OilandGas #CEOInterview #2024Plans #EnergyInvestment #ExplorationCorp #OilProduction #ResourceDiscovery #Investing #BusinessUpdate #OilIndustry #OperationalUpdate #FinancialNews #FossilFuel #DrillingProjects #ExplorationOpportunities #EnergySector #CorporateStrategy #OilReservoir #InvestmentOpportunity #CEOInsights #FinancialOutlook #MarketAnalysis #ProactiveInterview #EconomicNews#proactiveinvestor #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Good morning from London where the FTSE 100 is down around half a percent as it stands, a drop more than accounted for by a heavy fall in Endeavour Mining’s share price.

Endeavour is one of the few London-listed companies to be publishing news today, the first Friday of the new year, and its no surprise the announcement has hit the share price – CEO Sébastien de Montessus has been drummed out of the business for what the company calls “serious misconduct” relating to a $5.9mln irregular payment instruction issued by him in relation to an asset disposal undertaken by the Company. He disputes the implication by the way.

What other company news there is this morning is also of the bad kind, with the Indonesian government putting a spanner in the Pyx Resources’ works – changes to export rules mean that the premium zircon company has some more work to do before it can start exporting its titanium dioxide.

And there’s been another twist in the Reabold Resources saga, the firm’s nominated advisor Strand Hanson has said today that it would likely cease working with Reabold if a long-threatened shareholder coup succeeds next week. That could mean a suspension of its shares.

Zooming out now to round things off and Richard Hunter from Interactive Investor says the Federal Reserve’s “higher for longer” policy appears intact and will hurt growth, and here in the UK there’s some fresh house price data from the Halifax, they say prices rose for the third consecutive month in December. A slightly dreary end to the week but don’t let it dampen your spirits – have a great weekend from everybody here at Proactive

#ProactiveInvestors #FTSE100 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Hybrid Power Solutions CEO Francois Byrne joined Steve Darling from Proactive to discussed the company's journey and future plans. With eight years of experience, Hybrid Power Solutions specializes in providing industrial power solutions, initially focusing on the mining industry with fuel-free portable generators. Over time, the company has expanded its applications to various sectors, including construction, railway, mining, and the military, offering versatile charging options such as vehicle and solar charging capabilities.

Byrne emphasized the pivotal shift from diesel-dependent systems to clean, renewable energy solutions, underlining the company's commitment to sustainability and environmental responsibility. The interview unveiled Hybrid Power Solutions' innovative product, the Power Tower, designed to cater to both residential and commercial applications.

Looking ahead to 2024, the company's primary goal is to offer comprehensive turnkey solutions tailored to customers' specific power needs. These solutions prioritize efficiency, safety, and environmental sustainability. Hybrid Power Solutions aims to not only provide products but also address the complete spectrum of power challenges faced by its clients.

The CEO stressed the company's dedication to cost savings, enhanced operational safety, and environmental conservation. This commitment positions Hybrid Power Solutions as a green and forward-thinking alternative without compromising on performance. Investors seeking sustainable and forward-looking opportunities may find Hybrid Power Solutions an appealing choice in the evolving landscape of energy solutions.

#proactiveinvestors #hybridpowersolutuons #cse #hpss #otc #hpsif #RenewableEnergy #CleanTech #IndustrialPower #GreenInnovation #SustainableSolutions #PowerTower #EnergyTransition #FutureTech #CEOInterview #Innovation2024 #TurnkeySolutions #GreenTechRevolution #EcoFriendlyPower #PoweringTheFuture #EnergyStorage #ZeroEmissions #SmartEnergy #EnvironmentalSustainability #CleanEnergySolutions #TechInnovation #PoweringIndustries #ResidentialPower #GreenBusinessLeadership #HybridPowerCEO

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce the launch of their AI-Powered 3D model search engine. This groundbreaking AI search engine incorporates computer vision and artificial intelligence to streamline and accelerate the 3D modeling process.

Gappelberg explained that the AI-based search engine uses images to search Nextech's internal library of 3D models, providing recommendations for models that closely match the given image. This innovative technology significantly expedites the 3D model creation process, enabling Nextech to produce a greater number of 3D models efficiently. Within seconds, 3D artists can choose from multiple 3D matches, capitalizing on the company's library of pre-existing 3D models with similar colors, textures, and shapes.

The development of this AI 3D model search engine was an in-house achievement, showcasing Nextech's technical prowess and the expertise of their team of AI engineers and scientists. This innovation promises to enhance and streamline their 3D modeling operations, providing Nextech3D.ai with a competitive edge in the market.

#proactiveinvestors #nextech3d.ai #cse #NTAR #otcqb #metaverse #toggle3D

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Metals Energy Corp CEO James Sykes joined Steve Darling from Proactive to provide details about the company's upcoming inaugural drill program at the SourceRock lithium brine project near Thunder Bay, Ontario, set to commence in early January.

Sykes explained that SourceRock is a drill-ready project equipped with an exploration permit for up to 20 drill pads. Historical drilling and geophysical data have already identified saline brine drill targets within the project. However, these brines have never been tested for lithium or other essential elements. SourceRock is situated within an ancient sedimentary basin, possessing all the necessary criteria for potentially discovering Ontario's first lithium brines.

With government support and recognizing the project's importance, Sykes anticipates swift progress, with the drill crew expected on-site within a week. The interview concludes with a sense of excitement and anticipation, highlighting the potential positive outcomes for Metal Energy Corp and the broader lithium market. Stay tuned for updates as the company works to validate its ambitious lithium brine project in Ontario.

#proactiveinvestors #metalenergycorp #tsxv #merg #mining #nickel

#LithiumProject, #OntarioMining, #ResourceExploration, #GreenEnergy, #CleanTech, #MiningInnovation, #LithiumBrineDiscovery, #SustainableMining, #MineralExploration, #RenewableResources, #EnergyRevolution, #GlobalImpact, #MiningTechnology, #GreenEconomy, #FutureOfEnergy, #MineralResources, #LithiumDemand, #InnovationInMining, #OntarioBusiness, #EnvironmentalImpact, #EnergySustainability, #MiningUpdates, #InvestmentOpportunity#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive and founder Andrew Newland visits the Proactive London studio to speak with Thomas Warner after the liquid biopsy company announced what it calls "groundbreaking" clinical results from its latest research.

ANGLE's research focused on addressing cancer's progression and the challenges of evolving treatments. Newland explains that traditional oncology relies on tissue biopsy for targeted therapy, but this method becomes ineffective as cancer changes. ANGLE's solution involves analysing both circulating tumour DNA (from dead cancer cells) and living cancer cells in blood, using their Parsortix system.

This novel approach allows for repeated non-invasive biopsies, providing critical information on cancer evolution and treatment efficacy. Their study involved 47 patients with four cancer types (breast, lung, ovarian, prostate) and identified actionable cancer mutations in living cells, not found in dead cells. These findings could lead to more effective, personalised treatments, as many of these variants are targetable with existing FDA-approved drugs.

ANGLE's next steps involve commercialising this technology by offering services to pharmaceutical companies and publishing protocols for wider adoption. Their focus is on improving cancer patient outcomes through this innovative blood test method.

Additionally, ANGLE announced a significant contract with Eisai Inc., a large Japanese pharmaceutical company, to pilot their HER2 assay in clinical trials. This contract marks a major step in ANGLE's business growth and their commitment to advancing cancer treatment and diagnostics.

#ANGLEPLC #CancerResearch #OncologyInnovation #AndrewNewland #CancerDiagnostics #TargetedTherapy #CancerTreatment #BloodTestCancer #PersonalizedMedicine #OncologyNews #HealthcareTechnology #MedicalResearch #BreastCancer #LungCancer #OvarianCancer #ProstateCancer #CTDNAAnalysis #LivingCancerCells #FDAApprovedDrugs #PharmaceuticalPartnerships #Epsych #CancerTherapies #HealthTech #MedicalBreakthroughs #CancerProgression #ClinicalTrials #CancerCare #BioTech #OncologyInterview #HealthcareAdvancements #CancerAwareness #ProactiveInvestors #InsertCompanyName #InsertStockMarket #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews